What is Surgery Partners, Inc.'s 2028?

Surgery Partners, Inc. (SGRY) reported 2028 of $5.4M in Q4 2025.

Surgery Partners, Inc. SGRY 2028

2028 at other companies

Tenet HealthcareTHC

——

SolventumSOLV

——

McKessonMCK

——

Privia Health Group, Inc.PRVA

——

Other financials

Income statement

See full

Revenue$810.9M+4.5%

Operating income$65.8M+6.3%

Net income-$35.9M+4.8%

EPS (diluted)-$0.28+6.7%

Balance sheet

See full

Cash & equivalents$182.3M-20.5%

Total debt$5.1B+4.6%

Total equity$1.7B-3.0%

Total assets$8.0B+1.2%

Cash flow

See full

Operating cash flow$11.7M+95.0%

CapEx$16.0M-29.5%

Free cash flow-$4.3M+74.3%

Valuation

See full

Market cap$1.99B-49.1%

Profitability

See full

Gross margin23.1%—

Operating margin11.8%+1.2pp

Net margin-2.3%-0.9pp

FCF margin6.2%+0.8pp

Returns & leverage

See full

Return on equity-4.4%-1.6pp

Debt / equity3×+0.2×

Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: Surgery Partners, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Surgery Partners, Inc.'s 2028?: Surgery Partners, Inc. (SGRY) reported 2028 of $5.4M in Q4 2025.